Can a common steroid preserve lung function in a rare scarring lung disease?
NCT ID NCT07210008
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 27 times
Summary
This study tests whether the steroid prednisolone can slow the decline in lung function in people with fibrotic hypersensitivity pneumonitis, a lung disease that causes scarring and breathing problems. About 120 adults with mild to moderate lung impairment will receive either prednisolone or a placebo for 6 months. The main goal is to see if the steroid helps maintain lung capacity better than a dummy pill.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERSENSITIVITY PNEUMONITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.